Tudor Investment Corp’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-74,989
Closed -$4.06M 1663
2024
Q2
$4.06M Sell
74,989
-747
-1% -$40.5K 0.02% 497
2024
Q1
$5.31M Buy
75,736
+40,009
+112% +$2.81M 0.03% 394
2023
Q4
$2.98M Buy
+35,727
New +$2.98M 0.02% 589
2023
Q2
Sell
-32,241
Closed -$1.14M 1619
2023
Q1
$1.14M Buy
32,241
+13,878
+76% +$489K 0.02% 857
2022
Q4
$841K Sell
18,363
-45,495
-71% -$2.08M 0.02% 926
2022
Q3
$3.09M Buy
63,858
+33,154
+108% +$1.61M 0.07% 361
2022
Q2
$1.21M Buy
+30,704
New +$1.21M 0.03% 721
2021
Q3
Sell
-24,317
Closed -$481K 1627
2021
Q2
$481K Sell
24,317
-21,475
-47% -$425K 0.01% 1120
2021
Q1
$1.07M Buy
+45,792
New +$1.07M 0.02% 795
2017
Q2
Sell
-26,166
Closed -$336K 1080
2017
Q1
$336K Buy
26,166
+8,926
+52% +$115K 0.01% 929
2016
Q4
$209K Sell
17,240
-24,060
-58% -$292K 0.01% 1188
2016
Q3
$379K Buy
41,300
+24,830
+151% +$228K 0.01% 861
2016
Q2
$156K Buy
16,470
+1,462
+10% +$13.8K ﹤0.01% 1287
2016
Q1
$106K Sell
15,008
-12,664
-46% -$89.4K ﹤0.01% 1372
2015
Q4
$289K Buy
27,672
+8,080
+41% +$84.4K 0.01% 1096
2015
Q3
$131K Buy
19,592
+2,501
+15% +$16.7K ﹤0.01% 1341
2015
Q2
$115K Sell
17,091
-7,402
-30% -$49.8K ﹤0.01% 1365
2015
Q1
$166K Buy
24,493
+11,615
+90% +$78.7K 0.01% 1312
2014
Q4
$103K Sell
12,878
-1,350
-9% -$10.8K ﹤0.01% 1349
2014
Q3
$50K Sell
14,228
-24,741
-63% -$86.9K ﹤0.01% 1288
2014
Q2
$186K Buy
+38,969
New +$186K 0.01% 1052